AMAG News and Press, AMAG Pharmaceuticals Inc. From 07/27/20

Vyleesi® returned to Palatin Technologies Company focuses on optimizing marketed assets and development of its innovative pipeline WALTHAM, Mass., July 27, 2020 (GLOBE NEWSWIRE) --  AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced AMAG and Palatin Technolog...

AMAG Pharmaceuticals (NASDAQ: AMAG )   jumps 16%  premarket after entering into an exclusive licensing agreement with Norgine B.V., the European specialist pharmaceutical company to develop and commercialize ciraparantag in Europe, Australia and New Zealand. More new...

Agreement provides AMAG with $30 million upfront payment and eligibility to receive up to $260 million in development and commercial milestones in addition to sales royalties   Collaboration further advances the development of ciraparantag WALTHAM, Mass. and AMSTERDAM, Th...

WALTHAM, Mass., July 12, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced the poster presentation of data from two Phase 2 randomized, placebo-controlled, dose ranging studies which showed safety and efficacy of ciraparantag reversing the effects of ap...

Introduction to the Positive/Negative Forensic Value Stock Selections This quantitative study continues a series of multi-year test now using the top four forensic algorithms applied to detect bankruptcy risk, earnings manipulation, and financial irregularities. This forward testing study co...

AMAG Pharmaceuticals' (NASDAQ: AMAG ) Chief Financial Officer (CFO) and Chief Operating Officer (COO), Edward (Ted) Myles is leaving the Company. More news on: AMAG Pharmaceuticals, Inc., Healthcare stocks news, Read more ...

Company initiates CFO & COO succession plan; appoints internal seasoned finance leader as interim CFO Anthony Casciano assumes expanded role as AMAG’s COO WALTHAM, Mass., June 11, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced tha...

WALTHAM, Mass., May 27, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that management will participate at the Jefferies Virtual Global Healthcare Conference on Wednesday, June 3, 2020 at 4:00 p.m. Eastern Time. A live audio webcast of the virtual...

Transaction allows AMAG to advance its strategic focus on Feraheme, Makena and its pipeline, consistent with previously announced plans Millicent Pharma uniquely positioned to drive revenue growth of Intrarosa WALTHAM, Mass., May 21, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, In...

Preamble: COVID-19 might destroy huge swaths of the consumer economy as it runs its course (or it might not) but rather than predict epidemiological curves, we are better served finding opportunities in parts of the economy that have no real exposure to COVID. The one area that stands out...